Enabling non-invasive delivery of proteins across the mucosal barriers promises improved
patient compliance and therapeutic efficacies. Cell-penetrating peptides (CPPs) are …

Therapeutics based on proteins and peptides have profoundly transformed the landscape of
treatment for diseases, from diabetes mellitus to cancers, yet the short half-life and low …

The evolution of meta-biomaterials has opened up exciting new opportunities for mass
personalisation of biomedical devices. This research paper details the development of a …

Porous scaffolds have evolved, allowing personalised 3D-printed structures that can
improve tissue reconstruction. By using scaffolds with specific porosity, Poisson's ratio and …

The aim of this work was to develop fast disintegrating dosage forms, including fast
disintegrating tablets (FDTs) and films (FDFs), for oral insulin delivery incorporating …

The current study aimed to optimize a bilosomal gel (bilo-gel) formulation loaded with anti-
diabetic empagliflozin. Enhancement of transdermal delivery of empagliflozin was targeted …

Buccal drug-delivery systems present a promising approach for the drug delivery to the
buccal mucosa, addressing oral cavity-specific problems, enabling systemic delivery and …

In the present study, extract (E) and bio-ferment (B) were obtained from ground and defatted
thistle seeds of Silybum marianum. Their antioxidant activity was assessed using the DPPH …

Nitrofurantoin (NTF) is a first-line therapy for treating urinary tract infections. However, gastric
upset, short half-life, and poor bioavailability of NTF are major challenges for clinical use …

The oral delivery of protein therapeutics offers numerous advantages for patients but also
presents significant challenges in terms of development. Currently, there is limited …